Does TOPOTECAN Cause C-reactive protein increased? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of C-reactive protein increased have been filed in association with TOPOTECAN (HYCAMTIN). This represents 0.3% of all adverse event reports for TOPOTECAN.
12
Reports of C-reactive protein increased with TOPOTECAN
0.3%
of all TOPOTECAN reports
2
Deaths
12
Hospitalizations
How Dangerous Is C-reactive protein increased From TOPOTECAN?
Of the 12 reports, 2 (16.7%) resulted in death, 12 (100.0%) required hospitalization.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Off label use (390)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Disease progression (207)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which TOPOTECAN Alternatives Have Lower C-reactive protein increased Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE